Lead Software Engineer wanted by Insitro, Inc. in South San Francisco, CA. The Lead Software Engineer will work closely with a team of distinguished scientists and engineers to design and develop the critical lab software infrastructure. The duties of a Lead Software Engineer will include but are not limited to: working closely with a cross-functional team of scientists and engineers to identify challenges and solutions to improve the lab data applications and integrations; designing and implementing a rigorous and scalable landscape of applications and data processing pipelines that interact with high throughput biology automation platforms, with performance and scale in mind; designing, implementing and maintaining scalable backends and intuitive frontends for capturing, extracting, integrating and analyzing large volumes of scientific and lab operational data such as high-content microscopy and sequencing data; contributing to building state-of-the-art machine learning infrastructure to advance Insitro's expertise in biology and disease modeling; evaluating new technologies, practices and vendors that could increase scientific capabilities and/or efficiencies; ensuring solutions fit appropriately into the information ecosystem and ensuring the integrity of Insitro's data architecture.
Must have a Master's degree in Computer Science or a related field plus two (2) years exp. in same or similar position. In lieu of a Master's degree plus two (2) years of experience, we will accept a Bachelor's degree in Computer Science or a related field plus five (5) years of progressive experience in same or similar position. $215,197/yr Please send resume to: ta-resumes@insitro.com and refer to: Job Req. 2024-insitro-002P
Compensation & Benefits at insitro
Our target starting salary for successful US-based applicants for this role is $215,197/yr. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.In addition, insitro also provides our employees:
- 401(k) plan with employer matching for contributions
- Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees on our base plans), as well as mental health and well-being support
- Open, flexible vacation policy
- Paid parental leave
- Quarterly budget for books and online courses for self-development
- Support to occasionally attend professional conferences that are meaningful to your career growth and development
- New hire stipend for home office setup
- Monthly cell phone & internet stipend
- Access to free onsite baristas and cafe with daily lunch and breakfast
- Access to free onsite fitness center
- Commuter benefits
insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices.
All candidates can expect equitable treatment, respect, and fairness throughout the interview process.#LI-DNI
About insitro
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy.
insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience, oncology and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.